Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03493815 · ClinicalTrials.gov registry record · NA
A RCT of Ultrasound Guided IUD Insertion
A NA study of IUD Not Visible, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 1
- Study location
NCT03493815: Completed NA study of IUD Not Visible, sponsored by Milton S. Hershey Medical Center.
NCT03493815 is a NA study of IUD Not Visible that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03493815, a NA study of IUD Not Visible, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the utility of ultrasound guided IUD insertion compared to the traditional blind insertion at an academic health institute where the skill level of the provider can vary greatly. We hypothesize that ultrasound-guided insertion will lead lower IUD discontinuation rates and greater patient satisfaction.
Primary Outcome
IUD discontinuation rates during the 6-month post-insertion period
Conditions Studied
Interventions
- PROCEDURE Transabdominal Ultrasound Guided IUD Insertion
- PROCEDURE Traditional Blind IUD Insertion
Study Locations (1)
Pennsylvania
- Penn State Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2018-03-08 |
| Est. Completion | 2019-04-30 |
| Phase | NA |
What the finished NCT03493815 record still lists
NCT03493815 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with IUD Not Visible appearing as the primary indexed condition, and to 2 interventions - of which Transabdominal Ultrasound Guided IUD Insertion is the first listed.
NCT03493815 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03493815 about?
NCT03493815 is a clinical study titled "A RCT of Ultrasound Guided IUD Insertion". To determine the utility of ultrasound guided IUD insertion compared to the traditional blind insertion at an academic health institute where the skill level of the provider can vary greatly. We hypothesize that ultrasound-guided insertion will lead lower IUD discontinuation rates and greater patien...
What is the current status of trial NCT03493815?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2018-03-08. Estimated completion is 2019-04-30.
What conditions does trial NCT03493815 study?
This clinical trial studies the following conditions: IUD Not Visible.
What interventions are being tested in trial NCT03493815?
The interventions under investigation include: Transabdominal Ultrasound Guided IUD Insertion (PROCEDURE), Traditional Blind IUD Insertion (PROCEDURE).
Who is sponsoring clinical trial NCT03493815?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03493815 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03493815's enrollment target sits among peer trials
85 980th of 2000 higher than 1,018 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI